These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 16375881

  • 1. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
    Salehi Z, Mashayekhi F.
    Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
    [Abstract] [Full Text] [Related]

  • 2. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
    Graff JR, Konicek BW, Lynch RL, Dumstorf CA, Dowless MS, McNulty AM, Parsons SH, Brail LH, Colligan BM, Koop JW, Hurst BM, Deddens JA, Neubauer BL, Stancato LF, Carter HW, Douglass LE, Carter JH.
    Cancer Res; 2009 May 01; 69(9):3866-73. PubMed ID: 19383915
    [Abstract] [Full Text] [Related]

  • 3. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
    Pons B, Peg V, Vázquez-Sánchez MA, López-Vicente L, Argelaguet E, Coch L, Martínez A, Hernández-Losa J, Armengol G, Ramon Y Cajal S.
    Int J Oncol; 2011 Nov 01; 39(5):1337-45. PubMed ID: 21750861
    [Abstract] [Full Text] [Related]

  • 4. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
    Hu J, Straub J, Xiao D, Singh SV, Yang HS, Sonenberg N, Vatsyayan J.
    Cancer Res; 2007 Apr 15; 67(8):3569-73. PubMed ID: 17440067
    [Abstract] [Full Text] [Related]

  • 5. The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin.
    Kjellerup RB, Iversen L, Kragballe K, Johansen C.
    Br J Dermatol; 2009 Nov 15; 161(5):1059-66. PubMed ID: 19663871
    [Abstract] [Full Text] [Related]

  • 6. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO, Amirghahari N, Abreo F, Rong X, Caldito G, Jones ML, Zhou H, Smith M, Kimberly D, Glass J.
    Clin Cancer Res; 2004 Sep 01; 10(17):5820-7. PubMed ID: 15355912
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.
    Dubois L, Magagnin MG, Cleven AH, Weppler SA, Grenacher B, Landuyt W, Lieuwes N, Lambin P, Gorr TA, Koritzinsky M, Wouters BG.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1219-27. PubMed ID: 19251093
    [Abstract] [Full Text] [Related]

  • 8. Effect of N-terminal region of eIF4E and Ser65-phosphorylation of 4E-BP1 on interaction between eIF4E and 4E-BP1 fragment peptide.
    Tomoo K, Abiko F, Miyagawa H, Kitamura K, Ishida T.
    J Biochem; 2006 Aug 15; 140(2):237-46. PubMed ID: 16825247
    [Abstract] [Full Text] [Related]

  • 9. Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation.
    Vary TC, Lynch CJ.
    Am J Physiol Endocrinol Metab; 2006 Apr 15; 290(4):E631-42. PubMed ID: 16263769
    [Abstract] [Full Text] [Related]

  • 10. Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition.
    Dudkin L, Dilling MB, Cheshire PJ, Harwood FC, Hollingshead M, Arbuck SG, Travis R, Sausville EA, Houghton PJ.
    Clin Cancer Res; 2001 Jun 15; 7(6):1758-64. PubMed ID: 11410517
    [Abstract] [Full Text] [Related]

  • 11. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.
    Niedzwiecka A, Marcotrigiano J, Stepinski J, Jankowska-Anyszka M, Wyslouch-Cieszynska A, Dadlez M, Gingras AC, Mak P, Darzynkiewicz E, Sonenberg N, Burley SK, Stolarski R.
    J Mol Biol; 2002 Jun 07; 319(3):615-35. PubMed ID: 12054859
    [Abstract] [Full Text] [Related]

  • 12. Regulation of human eIF4E by 4E-BP1: binding analysis using surface plasmon resonance.
    Youtani T, Tomoo K, Ishida T, Miyoshi H, Miura K.
    IUBMB Life; 2000 Jan 07; 49(1):27-31. PubMed ID: 10772338
    [Abstract] [Full Text] [Related]

  • 13. Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.
    Yang HY, Xue LY, Xing LX, Wang J, Wang JL, Yan X, Zhang XH.
    Mol Med Rep; 2013 Feb 07; 7(2):537-42. PubMed ID: 23229050
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
    Mishra R, Miyamoto M, Yoshioka T, Ishikawa K, Matsumura Y, Shoji Y, Ichinokawa K, Itoh T, Shichinohe T, Hirano S, Kondo S.
    Int J Oncol; 2009 May 07; 34(5):1231-40. PubMed ID: 19360336
    [Abstract] [Full Text] [Related]

  • 16. Suppression of translation during in vitro maturation of pig oocytes despite enhanced formation of cap-binding protein complex eIF4F and 4E-BP1 hyperphosphorylation.
    Ellederova Z, Kovarova H, Melo-Sterza F, Livingstone M, Tomek W, Kubelka M.
    Mol Reprod Dev; 2006 Jan 07; 73(1):68-76. PubMed ID: 16211600
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structural scaffold for eIF4E binding selectivity of 4E-BP isoforms: crystal structure of eIF4E binding region of 4E-BP2 and its comparison with that of 4E-BP1.
    Fukuyo A, In Y, Ishida T, Tomoo K.
    J Pept Sci; 2011 Sep 07; 17(9):650-7. PubMed ID: 21661078
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.